Cholera toxin-B (CTB) modified protocells provide a novel delivery method to target motoneurons.
CTB-protocells display uptake by presynaptic axon terminals at neuromuscular junctions.
CTB-protocells showed greater motoneuron uptake compared to unmodified protocells.
CTB-protocells constitute a promising delivery vehicle for therapy in motoneuron diseases.